258 related articles for article (PubMed ID: 36093552)
21. Expression and prognostic analysis of Rho GTPase-activating protein 11A in lung adenocarcinoma.
Chen S; Duan H; Xie Y; Li X; Zhao Y
Ann Transl Med; 2021 May; 9(10):872. PubMed ID: 34164506
[TBL] [Abstract][Full Text] [Related]
22. Protein phosphatase 1 regulatory subunit 3G (PPP1R3G) correlates with poor prognosis and immune infiltration in lung adenocarcinoma.
Zhuo X; Chen L; Lai Z; Liu J; Li S; Hu A; Lin Y
Bioengineered; 2021 Dec; 12(1):8336-8346. PubMed ID: 34592886
[TBL] [Abstract][Full Text] [Related]
23. Elevated Heterogeneous Nuclear Ribonucleoprotein C Expression Correlates With Poor Prognosis in Patients With Surgically Resected Lung Adenocarcinoma.
Guo W; Huai Q; Zhang G; Guo L; Song P; Xue X; Tan F; Xue Q; Gao S; He J
Front Oncol; 2020; 10():598437. PubMed ID: 33569346
[TBL] [Abstract][Full Text] [Related]
24. AMICA1 is a diagnostic and prognostic biomarker and induces immune cells infiltration by activating cGAS-STING signaling in lung adenocarcinoma.
Feng Z; Zhang Y; He M; Han Y; Cai C; Liu S; Liu P; Chen Y; Shen H; Zeng S
Cancer Cell Int; 2022 Mar; 22(1):111. PubMed ID: 35248033
[TBL] [Abstract][Full Text] [Related]
25. Development and Validation of a Ferroptosis-Related Gene Signature for Overall Survival Prediction in Lung Adenocarcinoma.
Tian Q; Zhou Y; Zhu L; Gao H; Yang J
Front Cell Dev Biol; 2021; 9():684259. PubMed ID: 34307361
[No Abstract] [Full Text] [Related]
26. Competing endogenous RNA (ceRNA) hypothetic model based on comprehensive analysis of long non-coding RNA expression in lung adenocarcinoma.
Wang X; Su R; Guo Q; Liu J; Ruan B; Wang G
PeerJ; 2019; 7():e8024. PubMed ID: 31720124
[TBL] [Abstract][Full Text] [Related]
27. Interferon Regulatory Factor 4 Correlated With Immune Cells Infiltration Could Predict Prognosis for Patients With Lung Adenocarcinoma.
Li X; Zhai S; Zhang J; Zhang D; Wang S; Wang L; Yu J
Front Oncol; 2021; 11():698465. PubMed ID: 34195096
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value and immune infiltration of a novel stromal/immune score-related P2RY12 in lung adenocarcinoma microenvironment.
Yu L; Cao S; Li J; Han B; Zhong H; Zhong R
Int Immunopharmacol; 2021 Sep; 98():107734. PubMed ID: 34175738
[TBL] [Abstract][Full Text] [Related]
29. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
[TBL] [Abstract][Full Text] [Related]
30. B3GNT3 as a prognostic biomarker and correlation with immune cell infiltration in lung adenocarcinoma.
Wu Y; Luo J; Li H; Huang Y; Zhu Y; Chen Q
Ann Transl Med; 2022 Mar; 10(6):295. PubMed ID: 35434016
[TBL] [Abstract][Full Text] [Related]
31. Expression, Clinical Significance, Immune Infiltration, and Regulation Network of miR-3940-5p in Lung Adenocarcinoma Based on Bioinformatic Analysis and Experimental Validation.
Lin Z; Huang W; Xie Z; Yi Y; Li Z
Int J Gen Med; 2022; 15():6451-6464. PubMed ID: 35966511
[TBL] [Abstract][Full Text] [Related]
32. Analysis of Expression and Its Clinical Significance of the Secreted Phosphoprotein 1 in Lung Adenocarcinoma.
Guo Z; Huang J; Wang Y; Liu XP; Li W; Yao J; Li S; Hu W
Front Genet; 2020; 11():547. PubMed ID: 32595698
[TBL] [Abstract][Full Text] [Related]
33. CDCA3 Is a Novel Prognostic Biomarker Associated with Immune Infiltration in Hepatocellular Carcinoma.
Wang Z; Chen S; Wang G; Li S; Qin X
Biomed Res Int; 2021; 2021():6622437. PubMed ID: 33604380
[TBL] [Abstract][Full Text] [Related]
34. High Expression of
Chen Y; Zhou M; Gu X; Wang L; Wang C
Dis Markers; 2022; 2022():8789515. PubMed ID: 35855850
[TBL] [Abstract][Full Text] [Related]
35. CDCA4 as a novel molecular biomarker of poor prognosis in patients with lung adenocarcinoma.
Tan J; Chen F; Ouyang B; Li X; Zhang W; Gao X
Front Oncol; 2022; 12():865756. PubMed ID: 36185189
[TBL] [Abstract][Full Text] [Related]
36. High TLX1 expression correlates with poor prognosis and immune infiltrates in patients with lung adenocarcinoma.
Zhao L; Zheng H; Chen F; Lu H; Yu Q; Yan X; Chen X; Zhang Q; Bu Q
Curr Mol Med; 2023 Jun; ():. PubMed ID: 37340746
[TBL] [Abstract][Full Text] [Related]
37. Integrated analysis and validation reveal ACAP1 as a novel prognostic biomarker associated with tumor immunity in lung adenocarcinoma.
Wang N; Zhu L; Xu X; Yu C; Huang X
Comput Struct Biotechnol J; 2022; 20():4390-4401. PubMed ID: 36051873
[TBL] [Abstract][Full Text] [Related]
38. Comprehensive analysis to identify GNG7 as a prognostic biomarker in lung adenocarcinoma correlating with immune infiltrates.
Wei Q; Miao T; Zhang P; Jiang B; Yan H
Front Genet; 2022; 13():984575. PubMed ID: 36159963
[No Abstract] [Full Text] [Related]
39. HMGA1 is a Prognostic Biomarker and Correlated with Glycolysis in Lung Adenocarcinoma.
Ma Y; Ma X; Du B; Li X; Li Y
J Cancer; 2024; 15(10):2913-2927. PubMed ID: 38706894
[No Abstract] [Full Text] [Related]
40. Construction and comprehensive analysis of a ceRNA network to reveal potential prognostic biomarkers for lung adenocarcinoma.
Gao L; Zhang L
BMC Cancer; 2021 Jul; 21(1):849. PubMed ID: 34301211
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
